Similarly, MFAP2 overexpression reduced G1 phase cell proportion and increased those of S and G2/M phase cells in ovarian cancer, suggesting that MFAP2 could stimulate G1-S phase cell transition. Here, MFAP2 is linked to ovarian cancer.